Related Experiment Videos
RSK2 represses HSF1 activation during heat shock
1Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Cell Stress & Chaperones
|February 24, 2001
Summary
Heat shock transcription factor 1 (HSF1) activation is regulated by the protein kinase RSK2. RSK2 represses HSF1 DNA binding activity, particularly during heat shock, as shown in Coffin-Lowry syndrome cells lacking RSK2.
Area of Science:
- Molecular Biology
- Cellular Stress Response
Background:
- Heat shock transcription factor 1 (HSF1) activation is a complex process involving its translocation to the nucleus and DNA binding.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to activate HSF1.
- Previous research indicated that RSK2 phosphorylates HSF1 in vitro, an effect inhibited by NSAIDs.
Purpose of the Study:
- To investigate the role of RSK2 in HSF1 activation in vivo.
- To examine HSF1 activation in cells deficient in RSK2, specifically in the context of Coffin-Lowry syndrome.
Main Methods:
- Utilized cell lines from a patient with Coffin-Lowry syndrome (RSK2 deficient).
- Assessed HSF1-HSE DNA binding activity following treatment with sodium salicylate and heat shock.
- Compared HSF1 activation in Coffin-Lowry syndrome cells versus normal control cells.
Main Results:
- RSK2 slightly represses HSF1 activation in vivo at 37°C.
- HSF1-HSE DNA binding activity was slightly elevated in Coffin-Lowry syndrome cells after sodium salicylate treatment compared to untreated cells.
- Heat shock treatment induced significantly higher HSF1-HSE binding activity in Coffin-Lowry syndrome cells than in normal controls.
Conclusions:
- RSK2 plays a role in repressing HSF1-HSE DNA binding activity, especially during heat shock.
- While RSK2 is involved in HSF1 regulation, it is not the sole protein kinase suppressing HSF1-HSE binding at 37°C.
- These findings highlight RSK2 as a key repressor of HSF1 activity under thermal stress.